Truist Securities updated their financial model for Eli Lilly and Company (NYSE:LLY), leading to an increased price target on the pharmaceutical giant's shares. The new price target is set at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback